Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Enfermedades Infecciosas Y Microbiologia Clinica|March 23, 2011
New drugs for tuberculosis treatmentFrancesca Sánchez, José L López Colomés, Elsa Villarino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis StudyTimothy R Sterling, Ruth N Moro, Andrey S Borisov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2016
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and CanadaRuth N Moro, Andrey S Borisov, Jussi Saukkonen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2021
Genomic Epidemiology and Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Congregate Healthcare Facilities in Santa Clara County, CaliforniaTara MacCannell, Joshua Batson, Brandon Bonin, et al.
JAMA Pediatrics|January 13, 2015
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazidM Elsa Villarino, Nigel A Scott, Stephen E Weis, et al.
JAMA Network Open|December 3, 2021
Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020Scott A Nabity, Emily Han, Phil Lowenthal, et al.
AIDS (London, England)|June 1, 2016
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected personsTimothy R Sterling, Nigel A Scott, Jose M Miro, et al.
Annals of the American Thoracic Society|March 20, 2013
The association between symptoms and microbiologically defined response to tuberculosis treatmentCraig M Hales, Charles M Heilig, Richard Chaisson, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysisNicholas Winters, Robert Belknap, Andrea Benedetti, et al.
Infection Control and Hospital Epidemiology|May 20, 2022
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreak investigation in a hospital emergency department-California, December 2020-January 2021Ruoran Li, Elizabeth Beshearse, Deborah Malden, et al.
Pageof 3